Status:
NOT_YET_RECRUITING
co Ihibtory Receptor in Preeclampsia
Lead Sponsor:
Assiut University
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
Preeclampsia is a form of hypertensive pregnancy disorder with multiorgan involvement. It is characterized by new-onset hypertension and proteinuria after 20 weeks' gestation in a woman whose blood pr...
Detailed Description
T lymphocytes, as well as their regulatory subpopulations could possibly possess a part in PE . The changes in T cell subsets that may be seen in preeclampsia include low Treg activity, a shift toward...
Eligibility Criteria
Inclusion
- total of 41 women in third trimester pregnancy complicated with PE showing:
- Blood pressure ≥140/90 mmHg and
- Proteinuria ≥300 mg/24 hours with or without
- Edema in pregnant woman after week 20 of gestation (American Congress of Obstetricians and Gynecologists (ACOG2013) (17)
Exclusion
- B-Exclusion criteria • Patients with autoimmune, acute inflammatory, and chronic diseases, are excluded from the study.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 4 2025
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT05294952
Start Date
January 1 2025
End Date
November 4 2025
Last Update
February 5 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.